全文获取类型
收费全文 | 2055篇 |
免费 | 2篇 |
专业分类
电工技术 | 1篇 |
化学工业 | 21篇 |
金属工艺 | 3篇 |
机械仪表 | 2篇 |
建筑科学 | 7篇 |
能源动力 | 2篇 |
轻工业 | 4篇 |
石油天然气 | 1篇 |
无线电 | 4篇 |
一般工业技术 | 3篇 |
冶金工业 | 2002篇 |
自动化技术 | 7篇 |
出版年
2021年 | 2篇 |
2019年 | 2篇 |
2017年 | 1篇 |
2015年 | 1篇 |
2013年 | 3篇 |
2012年 | 1篇 |
2010年 | 2篇 |
2009年 | 2篇 |
2008年 | 2篇 |
2007年 | 3篇 |
2005年 | 3篇 |
2004年 | 1篇 |
2003年 | 3篇 |
2002年 | 5篇 |
2001年 | 1篇 |
2000年 | 6篇 |
1999年 | 71篇 |
1998年 | 610篇 |
1997年 | 353篇 |
1996年 | 207篇 |
1995年 | 111篇 |
1994年 | 105篇 |
1993年 | 127篇 |
1992年 | 18篇 |
1991年 | 28篇 |
1990年 | 23篇 |
1989年 | 37篇 |
1988年 | 34篇 |
1987年 | 42篇 |
1986年 | 33篇 |
1985年 | 20篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 10篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1977年 | 50篇 |
1976年 | 105篇 |
1975年 | 3篇 |
1973年 | 2篇 |
1961年 | 1篇 |
1955年 | 3篇 |
排序方式: 共有2057条查询结果,搜索用时 15 毫秒
101.
102.
V Breuil F Cosman L Stein W Horbert J Nieves V Shen R Lindsay DW Dempster 《Canadian Metallurgical Quarterly》1998,13(11):1721-1729
A 10-center cooperative clinical study with a new formulation of epirubicin hydrochloride injectable solution (Epirubicin-RTU) was conducted in patients with breast cancer. One course of treatment consisted of one intravenous administration of Epirubicin-RTU at the dose of 60 mg/m2 followed by a 3-week drug-free interval and concomitant daily administration of oral cyclophosphamide at 100 mg/day during the period between Days 1 through 14. At least, two courses of treatment were given. Among 20 registered cases, all 20 cases were eligible and 16 cases completed the whole course of the study. In 16 completers, PR was observed in 5 cases, indicating the efficacy rate of 31.3% (5/16).. No local irritation was observed at the injection sites. Adverse reactions frequently observed were leukopenia, neutropenia, anorexia, alopecia, and nausea/vomiting, which were all reversible and tolerable. From the above results, Adverse reactions both locally and systemically were tolerable. Intravenous administration of Epirubicin-RTU was considered to be useful for the treatment of breast cancer. 相似文献
103.
The role of practice guidelines in malpractice litigation has been discussed in some theoretical detail. Little information is available, however, on how courts use guidelines or on the effort of state legislatures to explicitly link guideline compliance with malpractice defenses. We review all relevant case law and legislative enactments to shed light on the influence of medical malpractice on guidelines. We also use data from a nationwide survey of malpractice attorneys to supplement our legal analysis. Although guidelines are being used for both inculpatory and exculpatory purposes in common-law litigation (a two-way street), legislatures are interested in applying them only for exculpatory purposes (a one-way street). 相似文献
104.
105.
106.
107.
108.
109.
The social environment and normative structure surrounding drinking have a reciprocal relationship in determining adolescent drinking patterns in high school and college. 相似文献
110.
CF Durham KR Alden JA Dalton J Carlson DW Miller SP Englebardt VJ Neelon 《Canadian Metallurgical Quarterly》1998,38(6):427-435
Calcium phosphate bone cements (CPBCs) are osteotransductive, i.e. after implantation in bone they are transformed into new bone tissue. Furthermore, due to the fact that they are mouldable, their osteointegration is immediate. Their chemistry has been established previously. Some CPBCs contain amorphous calcium phosphate (ACP) and set by a sol-gel transition. The others are crystalline and can give as the reaction product dicalcium phosphate dihydrate (DCPD), calcium-deficient hydroxyapatite (CDHA), carbonated apatite (CA) or hydroxyapatite (HA). Mixed-type gypsum-DCPD cements are also described. In vivo rates of osteotransduction vary as follows: gypsum-DCPD > DCPD > CDHA approximately CA > HA. The osteotransduction of CDHA-type cements may be increased by adding dicalcium phosphate anhydrous (DCP) and/or CaCO3 to the cement powder. CPBCs can be used for healing of bone defects, bone augmentation and bone reconstruction. Incorporation of drugs like antibiotics and bone morphogenetic protein is envisaged. Load-bearing applications are allowed for CHDA-type, CA-type and HA-type CPBCs as they have a higher compressive strength than human trabecular bone (10 MPa). 相似文献